These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2095893)

  • 1. Immunotherapy for ovarian cancer.
    Bookman MA
    Curr Opin Oncol; 1990 Oct; 2(5):893-900. PubMed ID: 2095893
    [No Abstract]   [Full Text] [Related]  

  • 2. Biologic therapy and immunotherapy for ovarian cancer.
    Bookman MA
    Curr Opin Oncol; 1991 Oct; 3(5):901-7. PubMed ID: 1751581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic therapy for ovarian cancer.
    Bookman MA
    Curr Opin Oncol; 1989 Oct; 1(1):112-8. PubMed ID: 2489941
    [No Abstract]   [Full Text] [Related]  

  • 4. The immunobiology and immunotherapy of ovarian cancer.
    Bookman MA; Bast RC
    Semin Oncol; 1991 Jun; 18(3):270-91. PubMed ID: 1710393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological therapy of ovarian cancer: current directions.
    Bookman MA
    Semin Oncol; 1998 Jun; 25(3):381-96. PubMed ID: 9633851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent immunologic advances affecting the management of ovarian cancer.
    Freedman RS
    Clin Obstet Gynecol; 1985 Dec; 28(4):853-71. PubMed ID: 4075635
    [No Abstract]   [Full Text] [Related]  

  • 7. Biologic and immunologic therapy of ovarian cancer.
    Bookman MA; Berek JS
    Hematol Oncol Clin North Am; 1992 Aug; 6(4):941-65. PubMed ID: 1500395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotherapy of cancer.
    Harris DT; Mastrangelo MJ
    Semin Oncol; 1989 Jun; 16(3):180-98. PubMed ID: 2658082
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunotherapy of breast cancer.
    Breitmeyer JB
    Cancer Treat Res; 1992; 60():331-56. PubMed ID: 1355996
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeting of interleukin 2 to human ovarian carcinoma by fusion with a single-chain Fv of antifolate receptor antibody.
    Melani C; Figini M; Nicosia D; Luison E; Ramakrishna V; Casorati G; Parmiani G; Eshhar Z; Canevari S; Colombo MP
    Cancer Res; 1998 Sep; 58(18):4146-54. PubMed ID: 9751627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive immunotherapy of ovarian carcinoma with bs-MAb-targeted lymphocytes: a multicenter study.
    Bolhuis RL; Lamers CH; Goey SH; Eggermont AM; Trimbos JB; Stoter G; Lanzavecchia A; di Re E; Miotti S; Raspagliesi F
    Int J Cancer Suppl; 1992; 7():78-81. PubMed ID: 1428412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiolabeled monoclonal antibodies for the diagnosis and treatment of ovarian carcinoma.
    Wahl RL
    Front Radiat Ther Oncol; 1990; 24():228-39. PubMed ID: 2187760
    [No Abstract]   [Full Text] [Related]  

  • 13. Modern immunotherapy of cancer.
    Ravikumar TS; Steele GD
    Adv Surg; 1991; 24():41-68. PubMed ID: 1996529
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental model for radioimmunotherapy of human ovarian carcinoma with I-131-labeled monoclonal antibody OC 125.
    Senekowitsch R; Schmid P; Möllenstädt S; Kriegel H; Pabst HW
    Strahlenther Onkol; 1989 Jul; 165(7):564-6. PubMed ID: 2749501
    [No Abstract]   [Full Text] [Related]  

  • 15. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
    Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC
    Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy of metastases.
    Schirrmacher V; Umansky V; Rocha M
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 3)():189-216. PubMed ID: 8815005
    [No Abstract]   [Full Text] [Related]  

  • 17. Monoclonal antibodies in cancer immunotherapy.
    Kimiz-Gebologlu I; Gulce-Iz S; Biray-Avci C
    Mol Biol Rep; 2018 Dec; 45(6):2935-2940. PubMed ID: 30311129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of ovarian cancer.
    Kirby TO; Huh W; Alvarez R
    Expert Opin Biol Ther; 2002 Apr; 2(4):409-17. PubMed ID: 11955278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The prospect of biologic therapy in ovarian cancer].
    Qian HN
    Zhonghua Fu Chan Ke Za Zhi; 1994 Jul; 29(7):386-8. PubMed ID: 8001411
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of targeted therapies for B-cell non-Hodgkin lymphoma and multiple myeloma.
    Hernandez-Ilizaliturri FJ; Gowda A; Czuczman MS
    Clin Adv Hematol Oncol; 2004 Sep; 2(9):606-18. PubMed ID: 16163245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.